OBJECTIVE: The hypothesis is that partial nuclear factor-kappaB (NF-kappaB) inhibition can alleviate cardiopulmonary dysfunction associated with ischemia and reperfusion injury following cardiopulmonary bypass and deep hypothermic circulatory arrest (CPB/DHCA) in a pediatric model. DESIGN: Animal case study. SUBJECTS: Two-week-old piglets (5-7 kg). INTERVENTIONS: Piglets received 100 microg/kg of SN50, a peptide inhibitor of NF-kappaB translocation and activation, 1 hour before CPB. The control group received saline. Animals were cooled to 18 degrees C with CPB, the piglets were in DHCA for 120 minutes, and the piglets were then rewarmed on CPB to 38 degrees C and maintained for 120 minutes after CPB/DHCA. MEASUREMENTS: Sonomicrometry and pressure catheters collected hemodynamic data. Transmural left and right ventricular tissues were obtained at the terminal time point for determination of NF-kappaB activity by enzyme-linked immunosorbent assay. Data are expressed as mean +/- sd. MAIN POINTS: Oxygen delivery was maintained at 76 +/- 13 mL/min at baseline and 75 +/- 5 mL/min at 120 minutes after CPB/DHCA (p = 0.75) in SN50-treated animals vs. 99 +/- 26 mL/min at baseline and 63 +/- 20 mL/min at 120 minutes in the untreated group (p = 0.0001). Pulmonary vascular resistance (dynes.sec.cm) increased from 124 +/- 59 at baseline to 369 +/- 104 at 120 minutes in the untreated piglets (p = 0.001) compared with SN50-treated animals (100 +/- 24 at baseline and 169 +/- 88 at 120 minutes, p = 0.1). NF-kappaB activity was reduced by 74% in left ventricles of SN50-treated compared with SN50-untreated animals (p < 0.001). Plasma endothelin-1 (pg/mL), an important vasoconstrictor regulated by NF-kappaB, increased from 2.1 +/- 0.4 to 14.2 +/- 5.7 in untreated animals (p = 0.004) but was elevated to only 4.5 +/- 2 with SN50 treatment (p = 0.005). CONCLUSIONS: Improvement of cardiopulmonary function after ischemia/reperfusion was associated with the reduction of NF-kappaB activity in piglet hearts. Maintenance of systemic oxygen delivery and alleviation of pulmonary hypertension after CPB/DHCA in piglets administered SN50, possibly through a reduction of circulating endothelin-1, suggest that selective inhibition of NF-kappaB activity may reduce ischemia and reperfusion injury after pediatric cardiac surgery.
OBJECTIVE: The hypothesis is that partial nuclear factor-kappaB (NF-kappaB) inhibition can alleviate cardiopulmonary dysfunction associated with ischemia and reperfusion injury following cardiopulmonary bypass and deep hypothermic circulatory arrest (CPB/DHCA) in a pediatric model. DESIGN: Animal case study. SUBJECTS: Two-week-old piglets (5-7 kg). INTERVENTIONS: Piglets received 100 microg/kg of SN50, a peptide inhibitor of NF-kappaB translocation and activation, 1 hour before CPB. The control group received saline. Animals were cooled to 18 degrees C with CPB, the piglets were in DHCA for 120 minutes, and the piglets were then rewarmed on CPB to 38 degrees C and maintained for 120 minutes after CPB/DHCA. MEASUREMENTS: Sonomicrometry and pressure catheters collected hemodynamic data. Transmural left and right ventricular tissues were obtained at the terminal time point for determination of NF-kappaB activity by enzyme-linked immunosorbent assay. Data are expressed as mean +/- sd. MAIN POINTS: Oxygen delivery was maintained at 76 +/- 13 mL/min at baseline and 75 +/- 5 mL/min at 120 minutes after CPB/DHCA (p = 0.75) in SN50-treated animals vs. 99 +/- 26 mL/min at baseline and 63 +/- 20 mL/min at 120 minutes in the untreated group (p = 0.0001). Pulmonary vascular resistance (dynes.sec.cm) increased from 124 +/- 59 at baseline to 369 +/- 104 at 120 minutes in the untreated piglets (p = 0.001) compared with SN50-treated animals (100 +/- 24 at baseline and 169 +/- 88 at 120 minutes, p = 0.1). NF-kappaB activity was reduced by 74% in left ventricles of SN50-treated compared with SN50-untreated animals (p < 0.001). Plasma endothelin-1 (pg/mL), an important vasoconstrictor regulated by NF-kappaB, increased from 2.1 +/- 0.4 to 14.2 +/- 5.7 in untreated animals (p = 0.004) but was elevated to only 4.5 +/- 2 with SN50 treatment (p = 0.005). CONCLUSIONS: Improvement of cardiopulmonary function after ischemia/reperfusion was associated with the reduction of NF-kappaB activity in piglet hearts. Maintenance of systemic oxygen delivery and alleviation of pulmonary hypertension after CPB/DHCA in piglets administered SN50, possibly through a reduction of circulating endothelin-1, suggest that selective inhibition of NF-kappaB activity may reduce ischemia and reperfusion injury after pediatric cardiac surgery.
Authors: Jodie Y Duffy; David P Nelson; Steven M Schwartz; Connie J Wagner; Steven M Bauer; Jefferson M Lyons; Jerri L McNamara; Jeffrey M Pearl Journal: Pediatr Crit Care Med Date: 2004-01 Impact factor: 3.624
Authors: Jeffrey M Pearl; David P Nelson; Steven M Schwartz; Connie J Wagner; Steven M Bauer; Elizabeth A Setser; Jodie Y Duffy Journal: Ann Thorac Surg Date: 2002-09 Impact factor: 4.330
Authors: Steven M Schwartz; JodieE Y Duffy; Jeffrey M Pearl; Semin Goins; Connie J Wagner; David P Nelson Journal: Pediatr Res Date: 2003-03-19 Impact factor: 3.756
Authors: Jeffrey M Pearl; Steven M Schwartz; David P Nelson; Connie J Wagner; Jefferson M Lyons; Steven M Bauer; Jodie Y Duffy Journal: Ann Thorac Surg Date: 2004-03 Impact factor: 4.330
Authors: Jun Zhang; Peipei Ping; Thomas M Vondriska; Xian-Liang Tang; Guang-Wu Wang; Ernest M Cardwell; Roberto Bolli Journal: Am J Physiol Heart Circ Physiol Date: 2003-06-26 Impact factor: 4.733
Authors: Sathyamangla V Naga Prasad; Zhong-Hui Duan; Manveen K Gupta; Venkata Suresh K Surampudi; Stefano Volinia; George A Calin; Chang-Gong Liu; Ashwin Kotwal; Christine S Moravec; Randall C Starling; Dianne M Perez; Subha Sen; Qingyu Wu; Edward F Plow; Carlo M Croce; Sadashiva Karnik Journal: J Biol Chem Date: 2009-07-29 Impact factor: 5.157
Authors: Jodie Y Duffy; Orlando Petrucci; R Scott Baker; Christopher T Lam; Casey A Reed; Danielle J Everman; Pirooz Eghtesady Journal: J Thorac Cardiovasc Surg Date: 2010-09-29 Impact factor: 5.209
Authors: Antonio DiGiandomenico; Ruth Ann Veach; Jozef Zienkiewicz; Daniel J Moore; Lukasz S Wylezinski; Martha A Hutchens; Jacek Hawiger Journal: PLoS One Date: 2014-10-20 Impact factor: 3.240
Authors: Sathyamangla V Naga Prasad; Manveen K Gupta; Zhong-Hui Duan; Venkata Suresh K Surampudi; Chang-Gong Liu; Ashwin Kotwal; Christine S Moravec; Randall C Starling; Dianne M Perez; Subha Sen; Qingyu Wu; Edward F Plow; Sadashiva Karnik Journal: PLoS One Date: 2017-03-22 Impact factor: 3.240